3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
23
Pancreatic Neoplasms
10
Colonic Neoplasms
8
Stomach Neoplasms
7
Esophageal Neoplasms
7
Rectal Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
5
Adenocarcinoma Of Esophagus
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Cholangiocarcinoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Ovarian Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Adenocarcinoma
3
Uterine Cervical Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Interventions
Letrozole
25
Fulvestrant
25
Specimen Handling
19
ribociclib
16
Capecitabine
16
pembrolizumab
14
palbociclib
14
Paclitaxel
14
Trastuzumab
13
Carboplatin
13
exemestane
12
abemaciclib
12
Tamoxifen
12
Anastrozole
12
Magnetic Resonance Spectroscopy
11
trastuzumab deruxtecan
8
pertuzumab
8
Biopsy
8
Goserelin
7
inavolisib
6
giredestrant
6
Cyclophosphamide
6
130-nm albumin-bound paclitaxel
6
patritumab deruxtecan
5
eribulin
5
elacestrant
5
Taxes
5
Standard of Care
5
Radiotherapy
5
Gonadotropin-Releasing Hormone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Fluorouracil
×
30 days
×
Clear all
No trials found.